FOOTHILL RANCH, Calif.,
Jan. 5, 2021 /PRNewswire/
-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in
dental lasers, announced today that Todd
Norbe, President and Chief Executive Officer and
John Beaver, Chief Operating Officer
and Chief Financial Officer, will be providing an overview of the
Company, as well as recent progress and achievements, at the H.C.
Wainwright BIOCONNECT 2021 Investor Conference, which takes place
January 11-14, 2021. A webcast of
BIOLASE's recorded company presentation will be available on-demand
beginning at 6:00 a.m. ET on
January 11th, and can be
accessed in the investor relations section of BIOLASE's website
at www.biolase.com.
Management will also be available for virtual one-on-one
meetings with investors during the event. To request a meeting
please contact your H.C. Wainwright representative or BIOLASE's
investor relations firm at tkehrli@evcgroup.com.
About BIOLASE, Inc.
BIOLASE is a medical device company that develops, manufactures,
markets, and sells laser systems in dentistry and medicine.
BIOLASE's products advance the practice of dentistry and
medicine for patients and healthcare professionals.
BIOLASE's proprietary laser products incorporate approximately
261 patented and 52 patent-pending technologies designed to provide
biologically and clinically superior performance with less pain and
faster recovery times. BIOLASE's innovative products
provide cutting-edge technology at competitive prices to deliver
superior results for dentists and patients.
BIOLASE's principal products are revolutionary dental laser
systems that perform a broad range of dental procedures, including
cosmetic and complex surgical applications. BIOLASE has
sold over 41,200 laser systems to date in over 80 countries around
the world. Laser products under development
address BIOLASE's core dental market and other adjacent
medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase
Express™, and laser dentistry, find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram
at www.instagram.com/waterlase_laserdentistry, and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered
trademarks of BIOLASE, Inc.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biolase-to-present-at-the-hc-wainwrights-bioconnect-2021-investor-conference-301200830.html
SOURCE BIOLASE, Inc.